India has emerged as one of the world’s leading destinations for liver transplantation — delivering outcomes equivalent to the best Western programmes at 20–30% of the cost. For a patient in the UK, UAE, USA, or Canada facing a transplant bill of £150,000–$500,000, the ability to receive equivalent care in Mumbai for ₹25–40 lakhs (approximately $30,000–$50,000 USD) is a life-changing option. As Associate Director of Hepatology and Liver Transplant at Gleneagles Hospital, Mumbai, I work with international patients from across Asia, the Middle East, East Africa, and the Western world. This guide answers every key question about liver transplantation in India.
Liver Transplant Cost in India: What to Expect in 2025
The total cost of a liver transplant in India varies based on the type of transplant, hospital, and complexity of the recipient’s condition. As a guide:
| Transplant Type | Approximate Cost (INR) | Approximate Cost (USD) |
|---|---|---|
| Living Donor Liver Transplant (LDLT) | ₹25–45 lakhs | $30,000–$55,000 |
| Deceased Donor Liver Transplant (DDLT) | ₹20–35 lakhs | $24,000–$42,000 |
| Re-transplantation | ₹40–60 lakhs | $48,000–$72,000 |
These figures include surgery, ICU stay, hospital stay (typically 4–6 weeks), immunosuppression for the first 3 months, and outpatient follow-up. They do not include donor evaluation workup, international travel, accommodation, or visa costs.
For context: a comparable liver transplant in the UK costs £100,000–£150,000 privately; in the USA, $300,000–$500,000; and in the UAE, $150,000–$250,000. India’s cost advantage is real and substantial — without compromising outcomes.
Liver Transplant Success Rate in India
Outcomes at leading Indian transplant centres are directly comparable to international benchmarks. At Gleneagles Hospital Mumbai and other high-volume centres:
- 1-year patient survival: >90% for living donor transplants
- 5-year patient survival: 75–82%
- Graft survival at 1 year: >88%
- Operative mortality: <5% at high-volume centres
These figures are consistent with data from the European Liver Transplant Registry (ELTR) and UNOS (United States). The key driver is volume — high-volume centres with dedicated hepatology, transplant surgery, and anaesthesia teams achieve outcomes independent of geography.
Living Donor vs Deceased Donor Transplant in India
Living Donor Liver Transplant (LDLT)
LDLT is the dominant modality in India, accounting for over 80% of all transplants performed, because the deceased donor pool is small (organ donation rates remain low despite improvement). A healthy family member — typically a first- or second-degree relative aged 18–55 with a compatible blood group — donates their right lobe (60–70% of the liver). Both livers regenerate to full size within 6–8 weeks.
Advantages of LDLT: Shorter waiting time (planned surgery), better-quality graft, lower cold ischaemia time, higher success rates in experienced hands. Key requirement: A willing, medically suitable donor is needed. If no family donor is available, the deceased donor list (ZCCK for Maharashtra, NOTTO nationally) is the route.
Deceased Donor Liver Transplant (DDLT)
DDLT in India is governed by the Transplantation of Human Organs and Tissues Act (THOTA) and allocated through state and national registries (ZCCK in Maharashtra, NOTTO nationally). Waiting times vary from weeks to months depending on blood group and MELD score. For international patients, registration on the NOTTO list requires prior consultations and documentation — I assist international patients through this process.
The 4-Phase Liver Transplant Process
Phase 1 — Pre-Transplant Evaluation
A comprehensive workup assesses the recipient’s liver function (MELD/PELD score, Child-Pugh class), cardiovascular fitness, respiratory function, renal status, nutritional state, and absence of active infection or malignancy outside the liver. For LDLT, the donor undergoes a thorough medical, psychological, and volumetric CT assessment to confirm safety and suitability. This phase typically takes 1–2 weeks for in-person assessment, or can begin remotely via our virtual liver clinic — patients send their records, imaging, and labs in advance so that the evaluation is substantially complete before they travel.
Phase 2 — Optimisation and Listing
Before surgery, the recipient is medically optimised: infections treated, nutrition improved (targeting 1.2–1.5 g/kg/day protein, late evening snack), complications of portal hypertension stabilised. Sarcopenia — muscle wasting — is a powerful independent predictor of post-transplant outcomes and receives specific attention in our programme. For patients on a waiting list, MELD score dictates priority — higher MELD = earlier access to deceased donor grafts.
Phase 3 — Surgery
Liver transplantation is a 10–14 hour procedure performed under general anaesthesia by a dedicated multi-disciplinary team including transplant hepato-biliary surgeons, hepatologists, transplant anaesthetists, and scrub nurses. The diseased liver is removed and replaced with the donor graft. The hepatic artery, portal vein, hepatic veins, and bile duct are reconstructed sequentially. Patients typically spend 5–7 days in the ICU before transfer to the ward.
Phase 4 — Post-Transplant Recovery and Long-Term Follow-Up
Total hospital stay is typically 4–6 weeks. Post-discharge, patients require twice-weekly blood monitoring for the first month, then monthly. Immunosuppression (typically tacrolimus ± mycophenolate ± prednisolone) is carefully titrated to balance rejection risk against infection. For international patients, I coordinate closely with local physicians in the patient’s home country for ongoing monitoring, providing detailed protocols and remaining available for teleconsultation. Most patients from the UK, UAE, or USA can safely return home 6–8 weeks after transplantation.
Why Choose Mumbai for Liver Transplantation?
- World-class outcomes at Indian costs — 90%+ 1-year survival, 20–30% of Western pricing
- High-volume experience — Gleneagles Hospital Mumbai and affiliated centres perform hundreds of transplants annually
- Dedicated international patient pathway — FRRO medical visa support, interpreter services, accommodation coordination, and direct line to the transplant hepatologist
- Remote pre-evaluation — start the workup before you travel; arrive ready for surgery
- Regulatory transparency — THOTA-governed, NOTTO/ZCCK registered, fully compliant with international standards
Frequently Asked Questions — Liver Transplant Cost India
What is the total cost of a liver transplant in India for a foreigner?
For an international patient, the total cost including surgery, ICU, hospital stay, and first 3 months of immunosuppression is typically ₹30–50 lakhs ($36,000–$60,000 USD) for a living donor transplant. Add approximately $3,000–$8,000 for accommodation and living expenses during the recovery period. This is still 70–80% less than transplantation in the UK, USA, or UAE.
Can I get a liver transplant in India as a foreign national?
Yes, with a medical visa (MV). Foreign nationals can receive LDLT in India using a related living donor who travels with them, or can register on the NOTTO deceased donor waitlist (with restrictions). The Indian government specifically facilitates medical tourism through a streamlined MV visa process. I coordinate the full pathway from initial virtual consultation to visa letter support for patients from the UK, UAE, USA, Canada, East Africa, and Australia.
How long do I need to stay in India after liver transplantation?
Plan for a minimum of 6–8 weeks in-country after the transplant: 4–6 weeks in hospital (ICU + ward), followed by 2 weeks of close outpatient monitoring before your hepatologist clears you to fly. Most international patients from short-haul destinations (UAE, East Africa) can return in 6 weeks; long-haul patients (UK, USA, Canada) typically wait 8 weeks to ensure safe air travel.
How do I start the process of liver transplant evaluation from abroad?
Begin with a virtual consultation — send your latest liver function tests, ultrasound or MRI abdomen, FibroScan report, MELD score calculation, and a summary of your diagnosis. I review all records remotely and provide a written pre-evaluation opinion within 48–72 hours. If transplantation is appropriate, I guide you on the next steps for travel, visa, donor workup, and admission. Contact through the international patients page.
Dr. Chetan Kalal is Associate Director of Hepatology and Liver Transplant at Gleneagles Hospital, Mumbai — the first DM Hepatologist of Maharashtra, two-time AASLD Foundation Young Investigator Award winner, and EASL Full Bursary recipient. ORCID: 0000-0002-5284-7890.
About the Author
Dr. Chetan Kalal — MBBS, MD (Internal Medicine), DM Hepatology (ILBS, New Delhi) — is the First DM Hepatologist of Maharashtra and Associate Director, Hepatology & Liver Transplant, at Gleneagles Hospital Mumbai. He has 26 peer-reviewed publications and serves on the APASL AARC Expert Panel. Fellow, National Academy of Medical Sciences (FNAMS). Learn more · Book appointment
